Evidence map›Paper›PMID 37275411›Full record

ArticleSkin health and disease2023

Paraneoplastic pemphigus: Diagnostic mimics, confounders and management challenges in a series of five long-term survivors from a single centre.

Jonathan S Emerson, Mark Schifter, Pei Dai, Jocelyn Jiang, Mark S Taylor, Michelle Kang, Kenelm Kwong, Hadleigh Clark, Suzanne Cullican, David Campbell and 1 more

Abstract readCase Reports
In one paragraph

Article in Skin health and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jonathan S EmersonDepartment of Clinical Immunology and Immunopathology Westmead Hospital Sydney New South Wales Australia.ORCID https://orcid.org/0000-0001-9359-3834
Mark SchifterDepartment of Oral Medicine, Oral Pathology and Special Needs Dentistry Westmead Centre for Oral Health Westmead Hospital Sydney New South Wales Australia.
Pei DaiDepartment of Clinical Immunology and Immunopathology Westmead Hospital Sydney New South Wales Australia.
Jocelyn JiangDepartment of Clinical Immunology and Immunopathology Westmead Hospital Sydney New South Wales Australia.
Mark S TaylorDepartment of Clinical Immunology and Immunopathology Westmead Hospital Sydney New South Wales Australia.
Michelle KangDepartment of Oral Medicine, Oral Pathology and Special Needs Dentistry Westmead Centre for Oral Health Westmead Hospital Sydney New South Wales Australia.
Kenelm KwongDepartment of Oral Medicine, Oral Pathology and Special Needs Dentistry Westmead Centre for Oral Health Westmead Hospital Sydney New South Wales Australia.
Hadleigh ClarkDepartment of Oral Medicine, Oral Pathology and Special Needs Dentistry Westmead Centre for Oral Health Westmead Hospital Sydney New South Wales Australia.
Suzanne CullicanDepartment of Clinical Immunology and Immunopathology Westmead Hospital Sydney New South Wales Australia.
David CampbellDepartment of Clinical Immunology and Immunopathology Westmead Hospital Sydney New South Wales Australia.
Ming-Wei LinDepartment of Clinical Immunology and Immunopathology Westmead Hospital Sydney New South Wales Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a series of five cases who presented to our institution with treatment-refractory mucosal ulceration, all of whom were subsequently diagnosed with paraneoplastic pemphigus (PNP). This case series highlights the diagnostic and treatment considerations for PNP - in particular, the steroid-dependent, recalcitrant, polymorphic manifestations; the combination of histopathological and clinical findings that may overlap with clinically similar diseases, for example, pemphigus vulgaris and lichen planus; the importance of immunopathological findings for its diagnosis, and the need for surveillance and management of life-threatening bronchiolitis obliterans.

Identifiers

PMID37275411
PMCPMC10233075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.